Interleukin-12 in Treating Women With Metastatic Breast Cancer Who Have Received High-Dose Chemotherapy and Peripheral Stem Cell Transplantation

NCT00003412 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

BIOLOGICAL: recombinant interleukin-12

Sponsor

Beth Israel Deaconess Medical Center

Collaborators

[object Object]